Ignite Creation Date:
2025-12-24 @ 9:56 PM
Ignite Modification Date:
2025-12-25 @ 7:34 PM
Study NCT ID:
NCT01116232
Status:
TERMINATED
Last Update Posted:
2019-03-26
First Post:
2010-05-03
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Sirolimus, Tacrolimus, Thymoglobulin and Rituximab as Graft-versus-Host-Disease Prophylaxis in Patients Undergoing Haploidentical and HLA Partially Matched Donor Hematopoietic Cell Transplantation
Sponsor:
Barbara Ann Karmanos Cancer Institute
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2010-08
Start Date Type:
None
Primary Completion Date:
2013-05
Primary Completion Date Type:
ACTUAL
Completion Date:
2013-06
Completion Date Type:
ACTUAL
First Submit Date:
2010-05-03
First Submit QC Date:
None
Study First Post Date:
2010-05-04
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2013-10-22
Results First Submit QC Date:
None
Results First Post Date:
2013-12-13
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-03-13
Last Update Post Date:
2019-03-26
Last Update Post Date Type:
ACTUAL